Captor Therapeutics S.A.
CTX.WAR
| Exchange: | WAR |
| Currency | Polish złoty |
| ISIN: | PLCPTRT00014 |
| Primary Ticker: | CTX.WAR |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Biotechnology |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Biotechnology |
| Gic Sub Industry: | Biotechnology |
| Description: | Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has various therapeutic molecules in the preclinical stage. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland. |
| Address: | Ul. Dunska 11, Wroclaw, Poland, 54-427 |
| Website: | https://www.captortherapeutics.com |
| Full Time Employees: | 105 |
| Updated On: | 2024-11-05 |
Highlights
| Market Capitalization: | 320804096 |
| Market Capitalization Mln: | 320.80 |
| EBITDA: | -42870000 |
| Wall Street Target Price: | 102.5 |
| Book Value: | 10.87 |
| Earnings Share: | -9.04 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | -2.50 |
| Operating Margin TTM: | -2.09 |
| Return On Assets TTM: | -0.38 |
| Return On Equity TTM: | -0.87 |
| Revenue TTM: | 18640000 |
| Revenue Per Share TTM: | 3.82 |
| Quarterly Revenue Growth YOY: | 1.05 |
| Gross Profit TTM: | 3245000 |
| Diluted Eps TTM: | -9.04 |
Valuation
| Price Sales TTM: | 17.21 |
| Price Book MRQ: | 6.43 |
| Enterprise Value: | 276229220 |
| Enterprise Value Revenue: | 14.81 |
| Enterprise Value Ebitda: | -19.48 |
Shares
| Shares Outstanding: | 4662850 |
| Shares Float: | 2713357 |
| Percent Insiders: | 40.04 |
| Percent Institutions: | 19.70 |
Technicals
| Beta: | 0.56 |
| 52 Week High: | 109.5 |
| 52 Week Low: | 59 |
| 50 Day MA: | 73.94 |
| 200 Day MA: | 78.40 |
Earnings
| Report Date: | 2024-09-05 |
| Date: | 2024-06-30 |
| Currency: | PLN |
| Eps Actual: | -2.14 |
| Report Date: | 2024-05-29 |
| Date: | 2024-03-31 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -2.47 |
| Report Date: | 2023-11-28 |
| Date: | 2023-09-30 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -3.71 |
| Report Date: | 2023-09-07 |
| Date: | 2023-06-30 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -6.91 |
| Report Date: | 2023-05-30 |
| Date: | 2023-03-31 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -3.38 |
| Report Date: | 2023-03-01 |
| Date: | 2022-12-31 |
| Currency: | PLN |
| Eps Actual: | -1.56 |
| Report Date: | 2022-11-24 |
| Date: | 2022-09-30 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -2.04 |
| Report Date: | 2022-09-02 |
| Date: | 2022-06-30 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -2.37 |
| Report Date: | 2022-05-30 |
| Date: | 2022-03-31 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -2.65 |
| Report Date: | 2021-12-31 |
| Date: | 2021-12-31 |
| Currency: | PLN |
| Eps Actual: | -2.64 |
| Report Date: | 2021-11-29 |
| Date: | 2021-09-30 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -2.14 |
| Report Date: | 2021-09-30 |
| Date: | 2021-06-30 |
| Before After Market: | After Market |
| Currency: | PLN |
| Eps Actual: | -1.81 |
| Date: | 2024-06-30 |
| Eps Actual: | -18.62 |
| Date: | 2022-12-31 |
| Eps Actual: | -8.64 |
| Date: | 2021-12-31 |
| Eps Actual: | -6.60 |